Viscoelastic interactions between polydeoxyribonucleotide and ophthalmic excipients

被引:7
|
作者
Kim, Iksoo [1 ]
Kim, Hyeongmin [1 ]
Park, Kyunghee [1 ]
Karki, Sandeep [1 ]
Khadka, Prakash [1 ]
Jo, Kanghee [1 ]
Kim, Seong Yeon [1 ]
Ro, Jieun [1 ]
Lee, Jaehwi [1 ]
机构
[1] Chung Ang Univ, Coll Pharm, Pharmaceut Formulat Design Lab, Seoul 156756, South Korea
关键词
Polydeoxyribonucleotide; ophthalmic formulation; pharmaceutical excipients; rheology; viscoelasticity; DYNAMICS COMPUTER-SIMULATION; DELIVERY-SYSTEMS; DRUG-DELIVERY; CLINICAL-EVALUATION; TISSUE-REPAIR; DNA; SODIUM; PDRN; NA+; K+;
D O I
10.3109/03639045.2015.1040417
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study investigated the interaction between polydeoxyribonucleotide (PDRN) and several ionic and nonionic isotonic agents, thickeners and a preservative that were employed as excipients in ophthalmic preparations. Interaction of each individual excipient and PDRN aqueous solution was evaluated by analyzing their rheological properties. Rheological properties of PDRN solutions were evaluated by dynamic oscillatory shear tests and values of elastic modulus (G), viscous modulus (G) and loss tangent (tan ) were used to assess the relative changes in viscoelastic properties. At given concentrations, sodium chloride was found to show alteration in viscoelastic properties of PDRN solution while nonionic isotonic agents like d-glucose and d-sorbitol did not alter them. Similarly, nonionic water soluble polymers like polyvinylpyrrolidone (PVP) and hydroxypropyl methylcellulose (HPMC) also did not interact with PDRN to alter the viscoelastic properties. However, there were changes observed when carbopol 940 was used as a thickener. Therefore, PDRN was found to interact with ionic excipients and the interactions were negligible when nonionic materials were examined, which suggests that nonionic excipients are suitable to be formulated with PDRN.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 50 条
  • [2] THE SUITABILITY OF CYCLODEXTRINS AS EXCIPIENTS IN OPHTHALMIC INDOMETHACIN SOLUTION
    VANDOORNE, H
    LERK, CF
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1988, 10 (02) : 100 - 100
  • [3] Interactions Analysis between Furazolidone and Excipients used in Pharmaceutical Forms
    Marian, Eleonora
    Jurca, Tunde
    Kacso, Irina
    Miclaus, Maria
    Bratu, Ioana
    REVISTA DE CHIMIE, 2013, 64 (11): : 1275 - 1278
  • [4] Hyaluronan as an ophthalmic viscoelastic device
    Balazs, Endre A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2008, 9 (04) : 236 - 238
  • [5] Removal of an ophthalmic viscoelastic device
    Sharma, N
    Dada, T
    Dada, VK
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2001, 27 (04): : 492 - 493
  • [6] Solid State Interactions Between Ketoprofen and Excipients in Solid Dosage Forms
    Dragan, Felicia
    Kacso, Irina
    Martin, Flavia
    Borodi, Gheorghe
    Bratip, Ioan
    Costuleanu, Marcel
    Sandu, Ioan Gabriel
    Poroch, Vladimir
    REVISTA DE CHIMIE, 2016, 67 (10): : 2043 - 2048
  • [7] Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations
    Kalinkova, GN
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 187 (01) : 1 - 15
  • [8] Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: Impact on bioequivalence
    Garcia-Arieta, Alfredo
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 65 : 89 - 97
  • [9] Inadvertent intrastromal injection of ophthalmic viscoelastic
    McConnell, Lindsay K.
    Winter, Timothy W.
    Olson, Richard J.
    Longmuir, Susannah Q.
    JOURNAL OF AAPOS, 2013, 17 (06): : 639 - 641
  • [10] Interactions between Active Ingredient Ranitidine and Clay Mineral Excipients in Pharmaceutical Formulations
    Wang, Lijuan
    Wang, Xisen
    Liao, Libing
    Wu, Qingfeng
    Yin, Hui
    Li, Zhaohui
    MATERIALS, 2020, 13 (23) : 1 - 12